Related Experiment Video
Updated: Jan 9, 2026

Human Pluripotent Stem Cell Based Developmental Toxicity Assays for Chemical Safety Screening and Systems Biology Data Generation
Published on: June 17, 2015
Methyl mercury pharmacokinetics in man: a five-compartment hybrid model
Fred Farris1, Ayda Awaness1, Arman Kiledjian1
1School of Pharmacy, West Coast University, Los Angeles, CA, USA.
Abstract:
A five-compartment hybrid model that simulates the pharmacokinetic behaviour of methyl mercury (MeHg) and its biotransformation (demethylation) product inorganic mercury (Hg(II)) in humans is described.This model accounts for demethylation of MeHg at two sites: one which is within the body and a second which is extracorporeal (presumably the gut lumen). Simulations indicate that approximately 85% of demethylation occurs in the gut lumen and 15% in body tissues.The two-compartment model for Hg(II) pharmacokinetics developed by Farris et al. serves as the basis for the five-compartment model and is embedded within its structure. Parameters from the two-compartment model are used to describe Hg(II) pharmacokinetics in the current model.The model is validated against previously published experimental data for two human subjects dosed with MeHg.Model simulations showing the effects of decreased biotransformation of MeHg in the gastrointestinal lumen are discussed.
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Compartment Models
Two primary types of compartment models are recognized: mammillary and catenary. The more...
Mechanistic Models: Overview of Compartment Models
Multicompartment Models: Overview
These models offer a more comprehensive representation of drug behavior in the body than one-compartment models. They accommodate the complexity of drug distribution,...
Three-Compartment Open Model
Two-Compartment Open Model: Overview
The...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...

